Canada's CDRD links with Germany's LDC to support development of novel medicines

The Canadian Centre for Drug Research and Development (CDRD) and Germany-based Lead Discovery Center GmbH (LDC), two leading drug discovery and development centers supporting the commercialization of research from academic institutions across Canada, from select global partners, and from Germany’s Max Planck Institutes, have signed a partnership agreement to enable joint development of promising innovations from their broad networks.

The accord includes sharing infrastructure and expertise from LDC’s and CDRD’s drug development platforms in order to support the organizations’ shared objective of successfully translating basic research into high-quality commercial opportunities – and ultimately into new medicines that will benefit patients around the world.

CDRD and LDC set up to commercialize academic research